Autopsy report · NCT03712618
The SOLID Platelet Study
Cause of deathSlow enrollment
“Due to recruitment difficulty”
Life of this trial
- Registered 8 months before it started.
- Ran for about 2 years 2 months before it stopped.
- 2 participants enrolled.
- Results were posted on the registry 3 years 9 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- National Institutes of Health Clinical Center (CC)
- Sponsor type
- US National Institutes of Health
- Conditions
- Platelet Transfusion Refractoriness (PTR); Thrombocytopenia
- Interventions
- Platelet Transfusion - LONG Platelet Transfusion; Platelet Transfusion - SHORT Platelet Transfusion
- Participants
- 2
- Sites
- 1
- Countries
- United States
Trials that died the same way
- SHR1020 Plus Docetaxel as Compared to Placebo Plus Docetaxel in 2nd Line Non Squamous Non Small Cell Lung Cancer
“difficulty in recruitment” - Comparison of Dosimetry After rhTSH or Withdrawal of Thyroid Hormone in Metastatic or Locally Advanced Thyroid Cancer
“Recruitment difficulties” - Study to Compare hFSH-HP (Fostipur) and hMG-HP(Meriofert) in Patients With Polycystic Ovary Under a IVF/ICSI Cycle.
“Difficulties in recruitment” - Sensitivity of Frequent SARS-CoV-2 (COVID-19) Rapid Antigen Testing Regimen
“Difficulty with recruitment.” - A Comparison of the Effectiveness of Seroquel XR and Seroquel XR Plus Lithium in Patients With Acute Bipolar Mania: An Open-label, Randomized, Parallel Groups, Rater-blinded, 4 Week, Multicenter, Comparative,Study
“Difficulty of recruitment.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.